Bajrami, Albulena http://orcid.org/0000-0002-6322-9545
Tamanti, Agnese
Peloso, Angela
Ziccardi, Stefano http://orcid.org/0000-0003-0426-7223
Guandalini, Maddalena http://orcid.org/0000-0003-2341-9253
Calderone, Milena
Castellaro, Marco http://orcid.org/0000-0002-1203-2670
Pizzini, Francesca B. http://orcid.org/0000-0002-6285-0989
Montemezzi, Stefania
Marastoni, Damiano http://orcid.org/0000-0003-0358-9431
Calabrese, Massimiliano http://orcid.org/0000-0002-3362-7403
Funding for this research was provided by:
Università degli Studi di Verona
Article History
Received: 23 October 2023
Revised: 26 December 2023
Accepted: 27 December 2023
First Online: 30 January 2024
Declarations
:
: AB, AT, AP, SZ, MG, MC, MC, FBP, SM have no disclosures relevant to the manuscript. DM received honoraria for research or speaking and funds for travel from Biogen Idec, Roche, Sanofi-Genzyme, Novartis. MC received honoraria for research or speaking and funds for travel from Roche, Sanofi-Genzyme, Merck Serono S.p.a Italy, Biogen Idec, Teva and Novartis.
: The local Ethics Committee approved the present study, and informed consent was obtained from all patients.